More Globe Newswire

View Older Stories View Newer Stories

Oct 20, 2025 05:13AM A Gastronomic Extravaganza: World-Renowned Chefs and Fine Wines Unite at Hong Kong Wine & Dine Festival 2025
Oct 20, 2025 05:00AM Director Declaration
Oct 20, 2025 05:00AM Kaldalón hf.: Routine Announcement Regarding Share Buybacks Pursuant to Buyback Program
Oct 20, 2025 05:00AM Aicuris Presents Positive Phase 2 Results for Pritelivir and Favorable Phase 1 Safety Data for AIC468 at ID Week 2025
Oct 20, 2025 04:46AM Form 8.3 - Unite Group plc
Oct 20, 2025 04:35AM Prepayments (CK93) - Totalkredit A/S
Oct 20, 2025 04:35AM Prepayments (CK93) - Nykredit Realkredit A/S
Oct 20, 2025 04:30AM Festi hf.: Buyback program week 42
Oct 20, 2025 04:30AM Angelini Ventures Deepens Commitment to CoMind, a Neurotech Redefining Brain Monitoring, with Participation in $60 Million Round Bringing Total Funding to $102.5 Million
Oct 20, 2025 04:30AM Eimskip: Transaction in relation to a share buy-back program
Oct 20, 2025 04:15AM Patient-Reported Outcomes from VERITAC-2 Clinical Trial Support Clinical Benefit of Vepdegestrant in Patients with ESR1-Mutated, ER+/HER2- Advanced or Metastatic Breast Cancer Previously Treated with
Oct 20, 2025 04:04AM Data on debtor composition
Oct 20, 2025 04:03AM Coloplast A/S - FY 2024/25 Earnings Release - Invitation for conference call on 4 Nov 2025 at 11.00 CET
Oct 20, 2025 04:00AM Danske Bank share buy-back programme: transactions in week 42
Oct 20, 2025 04:00AM Entrepreneurs stay the course: 92% would choose this path again
Oct 20, 2025 04:00AM Perspective Therapeutics Presents Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET at the ESMO Congress 2025
Oct 20, 2025 04:00AM Niu Technologies to Report Third Quarter 2025 Financial Results on November 17, 2025
Oct 20, 2025 04:00AM ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors
Oct 20, 2025 03:53AM Prepayments, Realkredit Danmark A/S
Oct 20, 2025 03:51AM CoinEx Reinforces Transparency with Updated Proof of Reserve – October 2025
Oct 20, 2025 03:45AM Alm. Brand A/S – Weekly report on share buybacks
Oct 20, 2025 03:45AM Net Asset Value(s)
Oct 20, 2025 03:39AM Share buyback programme - week 42
Oct 20, 2025 03:38AM Preliminary data on early redemptions (prepayments)
Oct 20, 2025 03:36AM Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
Oct 20, 2025 03:34AM Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
Oct 20, 2025 03:24AM Columbus – Weekly report on share buyback
Oct 20, 2025 03:00AM NORBIT - Awarded NOK 120 million order
Oct 20, 2025 03:00AM Aspocomp will publish its January-September Interim Report 2025 on Thursday, October 30, 2025
Oct 20, 2025 03:00AM Municipality Finance issues SEK 1 billion tap under its MTN programme
Oct 20, 2025 03:00AM Municipality Finance issues a EUR 50 million tap under its MTN programme
Oct 20, 2025 03:00AM Medela AG Introduces the New Motion InBra™ Wearable Breast Pump – Where Dependable Performance Meets Everyday Comfort
Oct 20, 2025 02:49AM PRESS RELEASE: CMB.TECH NV announces fixed income investor meetings
Oct 20, 2025 02:48AM PRESS RELEASE: CMB.TECH trading update
Oct 20, 2025 02:30AM Debtor distribution data (CK92) - Totalkredit A/S
Oct 20, 2025 02:30AM Debtor distribution data (CK92) - Nykredit Realkredit A/S
Oct 20, 2025 02:30AM IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
Oct 20, 2025 02:30AM SOITEC: SOITEC AND CEA PARTNER TO DEVELOP AUTOMOTIVE CYBERSECURITY WITH ADVANCED FD-SOI TECHNOLOGY
Oct 20, 2025 02:30AM Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors
Oct 20, 2025 02:30AM Investa Launches Second Crowdcube Raise Following Record-Breaking 2024 Campaign
Oct 20, 2025 02:30AM Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
Oct 20, 2025 02:05AM Share repurchase programme: Transactions of week 42 2025
Oct 20, 2025 02:00AM Aktsiaselts Infortar to start buy-back of up to 250,000 own shares
Oct 20, 2025 02:00AM Further re pension contributions deferral
Oct 20, 2025 02:00AM Transaction in Own Shares
Oct 20, 2025 02:00AM Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 2)
Oct 20, 2025 02:00AM Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
Oct 20, 2025 02:00AM Lingokids Named to 2026 GSV 150: Recognized Among the World’s Most Transformational Growth Companies in Digital Learning & Workforce Skills
Oct 20, 2025 02:00AM VAALCO Schedules Third Quarter 2025 Earnings Release and Conference Call
Oct 20, 2025 02:00AM ST introduces new image sensors for industrial automation, security and retail applications
View Newer Stories View Older Stories